top of page

BLOG
Search


GSK: Step-Changing for Growth
Shoots of Change In July 2022, GlaxoSmithKline (GSK), a London-based global biopharma company, made a historic decision and demerged its...
Pavaki Capital
Nov 18, 20224 min read


NextEra Energy
We applaud the big climate-changing ideas of NextEra Energy. They emphasize clean energy, solar and wind. Wonderful for the world....
Pavaki Capital
Sep 30, 20227 min read


Is American Towers Towering Over Other Stocks?
Yes. To some extent. The stock price has substantially increased since the end of 2018. It rose by about 82%. Let us begin by examining...
Pavaki Capital
Jul 15, 20225 min read
![Xerox - A possible hidden gem [Updated]](https://static.wixstatic.com/media/9023d6_f441f419b8c542ccb7c9fecaa713da0a~mv2.png/v1/fill/w_333,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/9023d6_f441f419b8c542ccb7c9fecaa713da0a~mv2.webp)
![Xerox - A possible hidden gem [Updated]](https://static.wixstatic.com/media/9023d6_f441f419b8c542ccb7c9fecaa713da0a~mv2.png/v1/fill/w_454,h_341,fp_0.50_0.50,q_95,enc_avif,quality_auto/9023d6_f441f419b8c542ccb7c9fecaa713da0a~mv2.webp)
Xerox - A possible hidden gem [Updated]
With enthusiasm, we wrote a glowing commentary about Xerox on March 28, 2022. The company released Q1 2022 results and the stock declined...
Pavaki Capital
May 3, 20226 min read


Numis - Young & Growing
Are you looking for Goldman Sachs on the Thames? We call Numis baby-Goldman Sachs because, like Goldman Sachs, Numis provides key...
Pavaki Capital
Apr 14, 20222 min read


Xerox - A possible hidden gem
Short sellers evaluate companies including their financial statements, business models, management, and other items, forensically. Why?...
Pavaki Capital
Mar 28, 20225 min read
bottom of page